seed
Stage
1
Investors
About
Menten AI develops a generative AI platform, MAUD 1.0, that designs peptide macrocycles from scratch to target complex drug targets, combining AI with physics-based models and quantum simulations to accelerate peptide drug discovery.
Explore Menten AI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.